Long Covid Symptom Clusters, Correlates and Predictors in a Highly Vaccinated Australian Population in 2023
Essa Tawfiq, Rosalie Chen, Damian Alexander Honeyman, Rebecca Dawson, Mohana Kunasekaran, Adriana Notaras, Deepti Gurdasani, Helen Skouteris, Darshini Ayton, Chandini Raina Macintyre
Health Expectations, doi:10.1111/hex.70273
Background: Limited data exists regarding long Covid burden following Omicron infection in highly vaccinated populations. Objective: To (1) characterise long Covid prevalence and predictors and (2) identify key symptom clusters and their correlates among long Covid patients, during an Omicron-predominant period in a highly vaccinated population. Design: Anonymous, online, cross-sectional survey.
Author Contributions Essa Tawfiq: methodology, writingoriginal draft, writingreview and editing, formal analysis, investigation, data curation, visualization. Rosalie Chen: methodology, investigation, visualization, formal analysis, writingreview and editing, writingoriginal draft, data curation. Damian Alexander Honeyman: writingoriginal draft, writingreview and editing, methodology, formal analysis, investigation, visualization, data curation. Rebecca Dawson: methodology, formal analysis, investigation. Mohana Kunasekaran: writingreview and editing, methodology. Adriana Notaras: writingreview and editing, methodology. Deepti Gurdasani: methodology, supervision, writingreview and editing, data curation, investigation, writingoriginal draft. Helen Skouteris: conceptualization, writingreview and editing. Darshini Ayton: conceptualization, writingreview and editing. Chandini Raina MacIntyre: conceptualization, methodology, resources, funding acquisition, writingreview and editing, supervision, data curation, investigation, writingoriginal draft.
Ethics Statement This study was approved by the UNSW Human Research Ethics Committee (approval number HC220737).
Conflicts of Interest
Supporting Information Additional supporting information can be found online in the Supporting Information section.
References
Adekunle, Meehan, Rojas-Alvarez, Trauer, Mcbryde, Delaying the COVID-19 Epidemic in Australia: Evaluating the Effectiveness of International Travel Bans, Australian and New Zealand Journal of Public Health
Adjaye-Gbewonyo, Vahratian, Perrine, Bertolli, Long COVID in Adults: United States, 2022, NCHS Data Brief,
doi:10.15620/cdc:132417
Adler, Gazit, Pinto, Long-COVID in Patients With a History of Mild or Asymptomatic SARS-CoV-2 Infection: A Nationwide Cohort Study, Scandinavian Journal of Primary Health Care
Akhtar, Trent, Moa, Tan, Fröbert et al., The Impact of COVID-19 and COVID Vaccination on Cardiovascular Outcomes," supplement, European Heart Journal Supplements
Al-Aly, Davis, Mccorkell, Long COVID Science, Research and Policy, Nature Medicine
Antonelli, Pujol, Spector, Ourselin, Steves, Risk of Long COVID Associated With Delta Versus Omicron Variants of SARS-CoV-2, Lancet
Bager, Wohlfahrt, Bhatt, Risk of Hospitalisation Associated With Infection With SARS-CoV-2 Omicron Variant Versus Delta Variant in Denmark: An Observational Cohort Study, Lancet Infectious Diseases
Bahmer, Borzikowsky, Lieb, Severity, Predictors and Clinical Correlates of Post-COVID Syndrome (PCS) in Germany: A Prospective, Multi-Centre, Population-Based Cohort Study, eClinicalMedicine
Benjamini, Hochberg, Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing, Journal of the Royal Statistical Society Series B: Statistical Methodology
Bostanci, Gazi, Tosun, Long-COVID-19 in Asymptomatic, Non-Hospitalized, and Hospitalized Populations: A Cross-Sectional Study, Journal of Clinical Medicine
Byambasuren, Stehlik, Clark, Alcorn, Glasziou, Effect of Covid-19 Vaccination on Long Covid: Systematic Review, BMJ Medicine
Cabrera Martimbianco, Pacheco, Bagattini, Riera, Frequency, Signs and Symptoms, and Criteria Adopted for Long COVID-19: A Systematic Review, International Journal of Clinical Practice
Chang, Nguyen, Martiniuk, Sintchenko, Sorrell et al., Persistence of the Omicron Variant of SARS-CoV-2 in Australia: The Impact of Fluctuating Social Distancing, PLOS Global Public Health
Chen, Haupert, Zimmermann, Shi, Fritsche et al., Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long Covid: A Meta-Analysis and Systematic Review, Journal of Infectious Diseases
Core, R: A Language and Environment for Statistical Computing
Danielle, Débora, Alessandra, Correlating COVID-19 Severity With Biomarker Profiles and Patient Prognosis, Scientific Reports
Davis, Mccorkell, Vogel, Topol, Long COVID: Major Findings, Mechanisms and Recommendations, Nature Reviews Microbiology
Distance, Encyclopedia of Biometrics
Durstenfeld, Peluso, Peyser, Factors Associated With Long COVID Symptoms in an Online Cohort Study, Open Forum Infectious Diseases
Dynata, Dynata: World's Largest First Party Data Platform
Fang, Ahrnsbrak, Rekito, Evidence Mounts That About 7% of US Adults Have Had Long COVID, Journal of the American Medical Association
Fernández-De-Las-Peñas, Raveendran, Giordano, Arendt-Nielsen, Long COVID or post-COVID-19 Condition: Past, Present and Future Research Directions, Microorganisms
Griesel, Wagner, Mikolajewska, Inhaled Corticosteroids for the Treatment of COVID-19, Cochrane Database of Systematic Reviews
Hastie, Lowe, Mcauley, Outcomes Among Confirmed Cases and a Matched Comparison Group in the Long-COVID in Scotland Study, Nature Communications
Health Organization, A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus
Kenny, Mccann, O'brien, Identification of Distinct Long Covid Clinical Phenotypes Through Cluster Analysis of Self-Reported Symptoms, Open Forum Infectious Diseases,
doi:10.1093/ofid/ofac060
Kip, Mccreary, Collins, Evolving Real-World Effectiveness of Monoclonal Antibodies for Treatment of COVID-19: A Cohort Study, Annals of Internal Medicine
Klein, Flanagan, Sex Differences in Immune Responses, Nature Reviews Immunology
Lee, Bortolussi-Courval, Belga, Inhaled Corticosteroids for Outpatients With COVID-19: A Meta-Analysis, European Respiratory Journal
Loftus, Shickel, Balch, Phenotype Clustering in Health Care: A Narrative Review for Clinicians, Frontiers in Artificial Intelligence
Long, None
Luo, Zhang, Tang, Prevalence and Risk Factors of Long COVID 6-12 Months After Infection With the Omicron Variant Among Nonhospitalized Patients in Hong Kong, Journal of Medical Virology
Maechler, Rousseeuw, Struyf, Hubert, Hornik, Cluster Analysis Basics and Extensions, R Package Version
Magen, Waxman, Makov-Assif, Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting, New England Journal of Medicine
Munblit, Nicholson, Needham, Studying the Post-COVID-19 Condition: Research Challenges, Strategies, and Importance of Core Outcome Set Development, BMC Medicine
Mølbak, Sørensen, Bhatt, Lyngse, Simonsen et al., Severity of Respiratory Tract Infections Depends on the Infectious Dose. Perspectives for the Next Pandemic, Front Public Health
O'mahoney, Routen, Gillies, The Prevalence and Long-Term Health Effects of Long Covid Among Hospitalised and Non-Hospitalised Populations: A Systematic Review and Meta-Analysis, eClinicalMedicine
Pinto Pereira, Mensah, Nugawela, Long COVID in Children and Young After Infection or Reinfection With the Omicron Variant: A Prospective Observational Study, Journal of Pediatrics
Rousseeuw, Silhouettes: A Graphical Aid to the Interpretation and Validation of Cluster Analysis, Journal of Computational and Applied Mathematics
Stein, Ramelli, Grazioli, SARS-CoV-2 Infection and Persistence in the Human Body and Brain at Autopsy, Nature
Stoltzfus, Logistic Regression: A Brief Primer, Academic Emergency Medicine
Subramanian, Nirantharakumar, Hughes, Symptoms and Risk Factors for Long COVID in Non-Hospitalized Adults, Nature Medicine
Sun, Lin, Ai, Zhang, The Efficacy of Antivirals, Corticosteroids, and Monoclonal Antibodies as Acute COVID-19 Treatments in Reducing the Incidence of Long COVID: A Systematic Review and Meta-Analysis, Clinical Microbiology and Infection
Sunata, Miyata, Terai, Asthma Is a Risk Factor for General Fatigue of Long COVID in Japanese Nation-Wide Cohort Study, Allergology International
Vahratian, Adjaye-Gbewonyo, Lin, Saydah, Long COVID in Children: United States, 2022, NCHS Data Brief,
doi:10.15620/cdc:132416
Vegivinti, Evanson, Lyons, Efficacy of Antiviral Therapies for COVID-19: A Systematic Review of Randomized Controlled Trials, BMC Infectious Diseases
Whitaker, Elliott, Chadeau-Hyam, Persistent COVID-19 Symptoms in a Community Study of 606,434 People in England, Nature Communications
Woldegiorgis, Cadby, Ngeh, Long COVID in a Highly Vaccinated but Largely Unexposed Australian Population Following the 2022 SARS-CoV-2 Omicron Wave: A Cross-Sectional Survey, Medical Journal of Australia
Woodrow, Carey, Ziauddeen, Systematic Review of the Prevalence of Long COVID, Open Forum Infectious Diseases
Xie, Bowe, Al-Aly, Burdens of Post-Acute Sequelae of COVID-19 by Severity of Acute Infection, Demographics and Health Status, Nature Communications
Xie, Bowe, Al-Aly, Molnupiravir and Risk of Hospital Admission or Death in Adults With Covid-19: Emulation of a Randomized Target Trial Using Electronic Health Records, BMJ
Xie, Choi, Al-Aly, Molnupiravir and Risk of Post-Acute Sequelae of Covid-19: Cohort Study, BMJ
DOI record:
{
"DOI": "10.1111/hex.70273",
"ISSN": [
"1369-6513",
"1369-7625"
],
"URL": "http://dx.doi.org/10.1111/hex.70273",
"abstract": "<jats:title>ABSTRACT</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Limited data exists regarding long Covid burden following Omicron infection in highly vaccinated populations.</jats:p></jats:sec><jats:sec><jats:title>Objective</jats:title><jats:p>To (1) characterise long Covid prevalence and predictors and (2) identify key symptom clusters and their correlates among long Covid patients, during an Omicron‐predominant period in a highly vaccinated population.</jats:p></jats:sec><jats:sec><jats:title>Design</jats:title><jats:p>Anonymous, online, cross‐sectional survey.</jats:p></jats:sec><jats:sec><jats:title>Setting</jats:title><jats:p>January 2023, Australia.</jats:p></jats:sec><jats:sec><jats:title>Participants</jats:title><jats:p>Residents aged ≥ 18 years with self‐reported history of test‐positive Covid‐19.</jats:p><jats:p>The main variables studied were socio‐demographic characteristics, Covid‐19 risk factors, vaccination, infection history and experiences with long Covid.</jats:p></jats:sec><jats:sec><jats:title>Main Outcome Measures</jats:title><jats:p>Long Covid symptoms. Symptom‐based clustering was used to identify long Covid symptom clusters and their functional correlates. Predictors of long Covid occurrence and severity were assessed using multivariable logistic regression.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Overall, 240/1205 participants (19.9%) reported long Covid. Long Covid risk was significantly higher for women OR 1.71 (95% CI: 1.17–2.51), people with comorbidities 2.19 (95% CI: 1.56–3.08) and those using steroid inhalers for Covid‐19 treatment (2.34 [95% CI: 1.29–4.24]). Long‐Covid risk increased with increasing Covid‐19 infection severity (moderately severe symptoms: 2.23 [95% CI: 1.50–3.30], extremely severe symptoms: 5.80 [95% CI: 3.48–9.66], presented to ED/hospitalised: 7.22 [95% CI: 3.06–17.03]). We found no significant difference in the likelihood of long Covid between the Omicron and pre‐Omicron periods, vaccination status and participant age.</jats:p><jats:p>We identified two long Covid clusters (pauci‐symptomatic, <jats:italic>n</jats:italic> = 170, vs. polysymptomatic, <jats:italic>n</jats:italic> = 66). Polysymptomatic cluster membership was associated with worse functioning (impacts on work, moderate activity, emotions and energy). Severity acute infection was strongly predictive of polysymptomatic cluster membership (5.72 [2.04–17.58]). Monoclonal antibody treatment was strongly associated with pauci‐symptomatic cluster membership (0.02 [0.00–0.13]).</jats:p></jats:sec><jats:sec><jats:title>Discussion</jats:title><jats:p>Our study shows that long Covid is an important health burden in Australia, including during the Omicron era, and identifies several risk factors. We found a subgroup of patients characterised by more symptoms and worse functional outcomes. Our findings can inform policies for protecting vulnerable populations and frameworks for long Covid risk assessment and management.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>One‐in‐five people may suffer long Covid after acute Covid‐19 infection, with similar risk across age groups. Omicron variants appear not to have a lower risk compared to earlier variants in our study. A cumulative number of symptoms can help triage long Covid patients.</jats:p></jats:sec><jats:sec><jats:title>Patient or Public Contribution</jats:title><jats:p>We did not involve patients or the public in the design of the questionnaire. However, after a soft launch, we revised some survey questions by reviewing early responses from patients and the public.</jats:p></jats:sec>",
"alternative-id": [
"10.1111/hex.70273"
],
"assertion": [
{
"group": {
"label": "Publication History",
"name": "publication_history"
},
"label": "Received",
"name": "received",
"order": 0,
"value": "2024-07-05"
},
{
"group": {
"label": "Publication History",
"name": "publication_history"
},
"label": "Accepted",
"name": "accepted",
"order": 2,
"value": "2025-04-11"
},
{
"group": {
"label": "Publication History",
"name": "publication_history"
},
"label": "Published",
"name": "published",
"order": 3,
"value": "2025-05-08"
}
],
"author": [
{
"affiliation": [
{
"name": "Biosecurity Program The Kirby Institute, Faculty of Medicine and Health The University of New South Wales Sydney Australia"
}
],
"family": "Tawfiq",
"given": "Essa",
"sequence": "first"
},
{
"affiliation": [
{
"name": "Biosecurity Program The Kirby Institute, Faculty of Medicine and Health The University of New South Wales Sydney Australia"
}
],
"family": "Chen",
"given": "Rosalie",
"sequence": "additional"
},
{
"ORCID": "https://orcid.org/0000-0002-4339-1801",
"affiliation": [
{
"name": "Biosecurity Program The Kirby Institute, Faculty of Medicine and Health The University of New South Wales Sydney Australia"
}
],
"authenticated-orcid": false,
"family": "Honeyman",
"given": "Damian Alexander",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Biosecurity Program The Kirby Institute, Faculty of Medicine and Health The University of New South Wales Sydney Australia"
}
],
"family": "Dawson",
"given": "Rebecca",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Biosecurity Program The Kirby Institute, Faculty of Medicine and Health The University of New South Wales Sydney Australia"
}
],
"family": "Kunasekaran",
"given": "Mohana",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Biosecurity Program The Kirby Institute, Faculty of Medicine and Health The University of New South Wales Sydney Australia"
}
],
"family": "Notaras",
"given": "Adriana",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Biosecurity Program The Kirby Institute, Faculty of Medicine and Health The University of New South Wales Sydney Australia"
},
{
"name": "University of Western Australia Medical School University of Western Australia Perth Australia"
},
{
"name": "William Harvey Research Institute Queen Mary University of London London UK"
}
],
"family": "Gurdasani",
"given": "Deepti",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Health and Social Care Unit School of Public Health and Preventive Medicine, Monash University in collaboration with Monash Health Melbourne Australia"
}
],
"family": "Skouteris",
"given": "Helen",
"sequence": "additional"
},
{
"ORCID": "https://orcid.org/0000-0002-2754-2024",
"affiliation": [
{
"name": "Health and Social Care Unit School of Public Health and Preventive Medicine, Monash University in collaboration with Monash Health Melbourne Australia"
}
],
"authenticated-orcid": false,
"family": "Ayton",
"given": "Darshini",
"sequence": "additional"
},
{
"ORCID": "https://orcid.org/0000-0002-3060-0555",
"affiliation": [
{
"name": "Biosecurity Program The Kirby Institute, Faculty of Medicine and Health The University of New South Wales Sydney Australia"
},
{
"name": "College of Public Service & Community Solutions, and College of Health Solutions Arizona State University Tempe Arizona USA"
}
],
"authenticated-orcid": false,
"family": "MacIntyre",
"given": "Chandini Raina",
"sequence": "additional"
}
],
"container-title": "Health Expectations",
"container-title-short": "Health Expectations",
"content-domain": {
"crossmark-restriction": true,
"domain": [
"onlinelibrary.wiley.com"
]
},
"created": {
"date-parts": [
[
2025,
5,
8
]
],
"date-time": "2025-05-08T07:49:38Z",
"timestamp": 1746690578000
},
"deposited": {
"date-parts": [
[
2025,
6,
27
]
],
"date-time": "2025-06-27T05:53:41Z",
"timestamp": 1751003621000
},
"indexed": {
"date-parts": [
[
2025,
6,
28
]
],
"date-time": "2025-06-28T04:03:55Z",
"timestamp": 1751083435706,
"version": "3.41.0"
},
"is-referenced-by-count": 0,
"issue": "3",
"issued": {
"date-parts": [
[
2025,
5,
8
]
]
},
"journal-issue": {
"issue": "3",
"published-print": {
"date-parts": [
[
2025,
6
]
]
}
},
"language": "en",
"license": [
{
"URL": "http://creativecommons.org/licenses/by/4.0/",
"content-version": "vor",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2025,
5,
8
]
],
"date-time": "2025-05-08T00:00:00Z",
"timestamp": 1746662400000
}
}
],
"link": [
{
"URL": "https://onlinelibrary.wiley.com/doi/pdf/10.1111/hex.70273",
"content-type": "unspecified",
"content-version": "vor",
"intended-application": "similarity-checking"
}
],
"member": "311",
"original-title": [],
"prefix": "10.1111",
"published": {
"date-parts": [
[
2025,
5,
8
]
]
},
"published-online": {
"date-parts": [
[
2025,
5,
8
]
]
},
"published-print": {
"date-parts": [
[
2025,
6
]
]
},
"publisher": "Wiley",
"reference": [
{
"DOI": "10.1371/journal.pgph.0001427",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_2_1"
},
{
"key": "e_1_2_11_3_1",
"unstructured": "World Health Organization. “A Clinical Case Definition of Post COVID‐19 Condition by a Delphi Consensus ” retrieved November 6 2022 https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1."
},
{
"DOI": "10.1186/s12916-021-02222-y",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_4_1"
},
{
"DOI": "10.1093/infdis/jiac136",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_5_1"
},
{
"DOI": "10.15620/cdc:132417",
"doi-asserted-by": "crossref",
"key": "e_1_2_11_6_1",
"unstructured": "A.Adjaye‐Gbewonyo A.Vahratian C. G.Perrine andJ.Bertolli “Long COVID in Adults: United States 2022 ” NCHS Data Brief no 480 (National Center for Health Statistics 2023) https://doi.org/10.15620/cdc:132417."
},
{
"DOI": "10.1001/jama.2024.11370",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_7_1"
},
{
"key": "e_1_2_11_8_1",
"unstructured": "National Center for Health Statistics. U.S. Census Bureau Household Pulse Survey 2022–2024. Long COVID.2024 https://www.cdc.gov/nchs/covid19/pulse/long-covid.htm."
},
{
"key": "e_1_2_11_9_1",
"unstructured": "Office for National Statistics. Prevalence of Ongoing Symptoms Following Coronavirus (COVID‐19) Infection in the UK: 30 March 2023 https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/30march2023."
},
{
"DOI": "10.15620/cdc:132416",
"doi-asserted-by": "crossref",
"key": "e_1_2_11_10_1",
"unstructured": "A.Vahratian D.Adjaye‐Gbewonyo J. S.Lin andS.Saydah “Long COVID in Children: United States 2022 “NCHS Data Brief no 479(National Center for Health Statistics 2023) https://doi.org/10.15620/cdc:132416."
},
{
"DOI": "10.1038/s41591-024-03173-6",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_11_1"
},
{
"DOI": "10.1038/s41586-022-05542-y",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_12_1"
},
{
"DOI": "10.3390/microorganisms11122959",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_13_1"
},
{
"DOI": "10.1016/j.eclinm.2022.101762",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_14_1"
},
{
"DOI": "10.1038/s41579-022-00846-2",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_15_1"
},
{
"DOI": "10.1038/s41467-022-33415-5",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_16_1"
},
{
"DOI": "10.1002/jmv.28862",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_17_1"
},
{
"DOI": "10.1093/ofid/ofad047",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_18_1"
},
{
"DOI": "10.1093/ofid/ofad233",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_19_1"
},
{
"DOI": "10.1038/s41591-022-01909-w",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_20_1"
},
{
"DOI": "10.1016/j.alit.2023.11.003",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_21_1"
},
{
"DOI": "10.1080/02813432.2022.2139480",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_22_1"
},
{
"DOI": "10.3390/jcm12072613",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_23_1"
},
{
"DOI": "10.7326/M22-1286",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_24_1"
},
{
"article-title": "Inhaled Corticosteroids for the Treatment of COVID‐19",
"author": "Griesel M.",
"issue": "3",
"journal-title": "Cochrane Database of Systematic Reviews",
"key": "e_1_2_11_25_1",
"volume": "3",
"year": "2022"
},
{
"DOI": "10.1186/s12879-022-07068-0",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_26_1"
},
{
"article-title": "The Efficacy of Antivirals, Corticosteroids, and Monoclonal Antibodies as Acute COVID‐19 Treatments in Reducing the Incidence of Long COVID: A Systematic Review and Meta‐Analysis",
"author": "Sun G.",
"first-page": "1505–1513",
"journal-title": "Clinical Microbiology and Infection",
"key": "e_1_2_11_27_1",
"volume": "30",
"year": "2024"
},
{
"DOI": "10.5694/mja2.52256",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_28_1"
},
{
"DOI": "10.1016/S1473-3099(22)00154-2",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_29_1"
},
{
"DOI": "10.1016/S0140-6736(22)00941-2",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_30_1"
},
{
"DOI": "10.1016/j.jpeds.2023.113463",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_31_1"
},
{
"DOI": "10.1111/1753-6405.13016",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_32_1"
},
{
"key": "e_1_2_11_33_1",
"unstructured": "Australian Government Department of Health and Aged Care. COVID‐19 Vaccination Rollout Update.2021 https://www.health.gov.au/resources/collections/covid-19-vaccination-rollout-update#december-2022."
},
{
"key": "e_1_2_11_34_1",
"unstructured": "Dynata. Dynata: World's Largest First Party Data Platform2023 https://www.dynata.com/."
},
{
"DOI": "10.1038/s41598-024-71951-w",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_35_1"
},
{
"DOI": "10.1111/ijcp.14357",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_36_1"
},
{
"DOI": "10.1136/bmjmed-2022-000385",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_37_1"
},
{
"DOI": "10.1136/bmj-2022-072705",
"article-title": "Molnupiravir and Risk of Hospital Admission or Death in Adults With Covid‐19: Emulation of a Randomized Target Trial Using Electronic Health Records",
"author": "Xie Y.",
"doi-asserted-by": "crossref",
"journal-title": "BMJ",
"key": "e_1_2_11_38_1",
"volume": "380",
"year": "2023"
},
{
"DOI": "10.1183/13993003.02921-2021",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_39_1"
},
{
"author": "Australian Institute of Health and Welfare",
"key": "e_1_2_11_40_1",
"volume-title": "Long COVID in Australia—a Review of the Literature, Catalogue Number PHE 318",
"year": "2022"
},
{
"DOI": "10.1038/s41467-021-26513-3",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_41_1"
},
{
"DOI": "10.3389/fpubh.2024.1391719",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_42_1"
},
{
"DOI": "10.1111/j.1553-2712.2011.01185.x",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_43_1"
},
{
"DOI": "10.1111/j.2517-6161.1995.tb02031.x",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_44_1"
},
{
"DOI": "10.3389/frai.2022.842306",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_45_1"
},
{
"author": "R Core Team",
"key": "e_1_2_11_46_1",
"volume-title": "R: A Language and Environment for Statistical Computing",
"year": "2024"
},
{
"key": "e_1_2_11_47_1",
"unstructured": "M.Maechler P.Rousseeuw A.Struyf M.Hubert andK.Hornik Cluster Analysis Basics and Extensions. R Package Version 2.1.6.2023."
},
{
"author": "Hamming Distance",
"first-page": "668",
"key": "e_1_2_11_48_1",
"volume-title": "Encyclopedia of Biometrics",
"year": "2009"
},
{
"DOI": "10.1016/0377-0427(87)90125-7",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_49_1"
},
{
"key": "e_1_2_11_50_1",
"unstructured": "The Mathworks Inc. MATLAB version: 9.14.0.2337262 (R2023a).2022 https://www.mathworks.com."
},
{
"DOI": "10.1016/j.eclinm.2022.101549",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_51_1"
},
{
"DOI": "10.1038/s41467-022-29521-z",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_52_1"
},
{
"DOI": "10.1038/nri.2016.90",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_53_1"
},
{
"DOI": "10.1056/NEJMoa2201688",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_54_1"
},
{
"key": "e_1_2_11_55_1",
"unstructured": "Australian Government Department of Health and Aged Care. “ATAGI Update on the COVID‐19 Vaccination Program ” retrieved October 6 2023 https://www.health.gov.au/news/atagi-update-on-the-covid-19-vaccination-program?language=en."
},
{
"DOI": "10.1101/2022.11.03.22281783",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_56_1"
},
{
"article-title": "Molnupiravir and Risk of Post‐Acute Sequelae of Covid‐19: Cohort Study",
"author": "Xie Y.",
"journal-title": "BMJ",
"key": "e_1_2_11_57_1",
"volume": "381",
"year": "2023"
},
{
"DOI": "10.1093/ofid/ofac060",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_58_1"
},
{
"key": "e_1_2_11_59_1",
"unstructured": "Australian Bureau of Statistics. National State and Territory Population.2023 https://www.abs.gov.au/statistics/people/population/national-state-and-territory-population/latest-release#states-and-territories."
},
{
"key": "e_1_2_11_60_1",
"unstructured": "Australian Bureau of Statistics. A Caring Nation—15 Per Cent of Australia's Workforce in Health Care and Social Assistance Industry.2022 https://www.abs.gov.au/media-centre/media-releases/caring-nation-15-cent-australias-workforce-health-care-and-social-assistance-industry."
},
{
"DOI": "10.1093/eurheartjsupp/suac123",
"doi-asserted-by": "publisher",
"key": "e_1_2_11_61_1"
}
],
"reference-count": 60,
"references-count": 60,
"relation": {},
"resource": {
"primary": {
"URL": "https://onlinelibrary.wiley.com/doi/10.1111/hex.70273"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [],
"subtitle": [],
"title": "Long Covid Symptom Clusters, Correlates and Predictors in a Highly Vaccinated Australian Population in 2023",
"type": "journal-article",
"update-policy": "https://doi.org/10.1002/crossmark_policy",
"volume": "28"
}